# PHBI (Pharmagreen Biotech Inc.) - SEC EDGAR Financial Statements

> Pharmagreen Biotech Inc. reported $140K in total assets and a net loss of $501K through September 30, 2022 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/PHBI
- Markdown: https://convexityos.com/fundamentals/PHBI.md
- SEC CIK: 0001435181
- Reporting currency: USD
- Latest filing period: June 30, 2023
- Last synced: Nov 21, 2026, 05:16 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001435181&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2022 | -- | Sep 30, 2022 |
| Operating Income | FY 2022 | -$649K | Operating profit |
| Net Income | FY 2022 | -$501K | GAAP bottom line |
| Diluted EPS | FY 2022 | -- | Split-adjusted |
| Free Cash Flow | FY 2022 | -- | Operating CF less CapEx |
| Cash & ST Investments | Jun 30, 2023 | $5.3K | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- |
| Research & Development | -- | -- | -- | $4.0K | $7.6K |
| Total Operating Expenses | $1.10M | $744K | $486K | $642K | $749K |
| **Operating Income** | -$1.10M | -$744K | -$486K | -$642K | -$749K |
| Interest Expense | $29K | $681K | $299K | $3.8K | -- |
| Income Before Tax | -- | -- | -$2.48M | -$769K | -- |
| Income Tax Expense | $0 | $0 | $0 | -- | -- |
| **Net Income** | -$876K | -$4.53M | -$2.48M | -$768K | -$1.07M |
| Basic EPS | -- | -$0.02 | -$0.03 | -$0.01 | -$0.04 |
| **Diluted EPS** | -- | -$0.02 | -$0.03 | -$0.01 | -$0.04 |
| Basic Shares Outstanding | 403.7M | 293.7M | 82.1M | 74.1M | 24.8M |
| Diluted Shares Outstanding | 218.7M | 326.0M | 388.4M | 364.9M | 293.1M |

### Income Statement (Quarterly)

| Line Item | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $597 | $963 | -- | -- | $0 | $0 | -- | -- |
| Cost of Revenue | $389 | $985 | -- | -- | $0 | $0 | -- | -- |
| **Gross Profit** | $208 | -$22 | -- | -- | $0 | $0 | -- | -- |
| Total Operating Expenses | $82K | $120K | $181K | $198K | $241K | $459K | $204K | $273K |
| **Operating Income** | -$82K | -$188K | -$181K | -$198K | -$241K | -$1.04M | -$204K | -$273K |
| Interest Expense | $8.2K | $8.1K | $8.3K | -$2.1K | $11K | $10K | $10K | $7.6K |
| **Net Income** | -$163K | -$188K | -$39K | -$110K | $252K | -$1.04M | $19K | -$831K |
| Basic EPS | -- | -- | -- | -- | $0.00 | -- | $0.00 | -- |
| **Diluted EPS** | -- | -- | -- | -- | $0.00 | -- | $0.00 | -- |
| Basic Shares Outstanding | -- | -- | -- | -- | 406.6M | 394.4M | 384.2M | -- |
| Diluted Shares Outstanding | -- | -- | -- | -- | 613.5M | -- | -- | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $8.0K | $25K | $12K | $63K | $152K |
| **Cash & Short-Term Investments** | $8.0K | $25K | $12K | $63K | $152K |
| Accounts Receivable, Net | $383 | $290 | -- | -- | -- |
| Inventory | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $209K | -- | $266K | $189K | $198K |
| Property, Plant & Equipment, Net | -- | -- | -- | $441K | $251K |
| **Total Non-Current Assets** | $0 | -- | $0 | $441K | $251K |
| **Total Assets** | $209K | $373K | $266K | $630K | $449K |
| Accounts Payable | $645K | $580K | $455K | $830K | $590K |
| **Total Current Liabilities** | $1.91M | $2.03M | $3.17M | $1.46M | $1.84M |
| Long-Term Debt | -- | -- | $30K | -- | -- |
| **Total Non-Current Liabilities** | $119K | $39K | $33K | $1.6K | $693 |
| **Total Liabilities** | $2.03M | $2.07M | $3.20M | $1.46M | $1.84M |
| **Total Debt (incl. Leases)** | -- | -- | $30K | -- | -- |
| Common Stock | $442K | $381K | $96K | $76K | $72K |
| Retained Earnings | -$12.57M | -$11.70M | -$7.17M | -$4.73M | -$3.96M |
| Accumulated Other Comp. Income | $94K | -$8.4K | $37K | $48K | $39K |
| **Total Stockholders' Equity** | -$1.78M | -$1.69M | -$2.93M | -$834K | -$1.39M |
| Total Equity | -$1.82M | -$1.69M | -$2.93M | -$834K | -$834K |

### Balance Sheet (Quarterly)

| Line Item | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.3K | $7.4K | $25K | $8.0K | $24K | $3.0K | $10K | $25K |
| **Cash & Short-Term Investments** | $5.3K | $7.4K | $25K | $8.0K | $24K | $3.0K | $10K | $25K |
| Accounts Receivable, Net | $606 | $569 | $465 | $383 | $316 | $70 | -- | $290 |
| Inventory | $9.2K | $9.5K | -- | $0 | -- | -- | -- | -- |
| **Total Current Assets** | $51K | $74K | -- | $209K | -- | -- | -- | -- |
| **Total Non-Current Assets** | $89K | $89K | -- | $0 | -- | -- | -- | -- |
| **Total Assets** | $140K | $163K | $212K | $209K | $191K | $198K | $358K | $373K |
| Accounts Payable | $697K | $691K | $685K | $645K | $622K | $623K | $611K | $580K |
| **Total Current Liabilities** | $2.17M | $2.06M | $1.92M | $1.91M | $1.99M | $2.56M | $1.90M | $2.03M |
| **Total Non-Current Liabilities** | $120K | $91K | $91K | $119K | $138K | $44K | $41K | $39K |
| **Total Liabilities** | $2.29M | $2.15M | $2.01M | $2.03M | $2.13M | $2.60M | $1.94M | $2.07M |
| Common Stock | $464K | $455K | $455K | $442K | $424K | $397K | $385K | $381K |
| Retained Earnings | -$12.97M | -$12.80M | -$12.61M | -$12.57M | -$12.46M | -$12.72M | -$11.68M | -$11.70M |
| Accumulated Other Comp. Income | $48K | $79K | $82K | $94K | $13K | -$28K | -$11K | -$8.4K |
| **Total Stockholders' Equity** | -$2.10M | -$1.94M | -$1.75M | -$1.78M | -$1.89M | -$2.40M | -$1.58M | -$1.69M |
| Total Equity | -$2.15M | -$1.99M | -$1.80M | -$1.82M | -$1.94M | -$2.40M | -$1.58M | -$1.69M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- |
| Net Income | -$876K | -$4.53M | -$2.48M | -$769K | -$1.07M |
| Change in Receivables | -$93 | $5 | -- | -- | -- |
| Change in Payables | -- | -- | $293K | -- | -- |
| **Operating Cash Flow** | -$427K | -$206K | -$608K | -$318K | -$786K |
| Capital Expenditure | -- | -- | -- | -$196K | -$251K |
| **Free Cash Flow** | -- | -- | -- | -$514K | -$1.04M |
| **Investing Cash Flow** | -- | -- | -- | -$196K | -$251K |
| Common Stock Issued | -- | -- | $570K | $75K | $298K |
| **Financing Cash Flow** | $314K | $257K | $563K | $433K | $1.12M |
| **Net Change in Cash** | -$17K | $13K | -$50K | -$89K | $135K |

### Cash Flow Statement (Quarterly)

| Line Item | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$163K | -$267K | $39K | -$110K | $252K | -$998K | -$19K | -$831K |
| Change in Receivables | $409 | -$104 | -$82 | -$119 | -$194 | -$8 | $228 | -- |
| **Operating Cash Flow** | $7.5K | -$34K | -$19K | -$92K | -$130K | -$56K | -$149K | -$55K |
| Common Stock Issued | $0 | $0 | $0 | -- | -$6.5K | $26K | $92K | -- |
| **Financing Cash Flow** | $18K | $19K | $47K | $0 | $113K | $65K | $136K | $37K |
| **Net Change in Cash** | -$2.1K | -$18K | $17K | -$16K | $21K | -$7.4K | -$15K | -- |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -419.0% | -1214.8% | -932.5% | -121.8% | -238.9% |
| Current Ratio | 0.11x | -- | 0.08x | 0.13x | 0.11x |
| Quick Ratio | 0.11x | 0.01x | 0.00x | 0.04x | 0.08x |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -356.9% | -52.7% | -441.1% | -419.0% | -835.1% | -1003.4% | -1145.0% | -1214.8% |
| Current Ratio | 0.02x | 0.04x | -- | 0.11x | -- | -- | -- | -- |
| Quick Ratio | 0.02x | 0.03x | 0.01x | 0.11x | 0.01x | 0.00x | 0.01x | 0.01x |
| **Net Income Growth (YoY)** | -164.7% | -- | -310.3% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
